Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 2/2021

29.03.2021 | Schwerpunkt

Catheter mapping and ablation during pregnancy

verfasst von: Adele Greyling, Caterina Vlachou, Stefan Ailoaei, Tina Buchholz, Bettina Toth, Professor Sabine Ernst, MD PhD

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

A substantial number of pregnant women at some point experience cardiac arrhythmia, which is mostly treated by antiarrhythmic medication. In some instances, arrhythmias can be drug-resistant and pose a relevant risk to both mother and unborn child as they can result in hemodynamic compromise. In recent years, invasive electrophysiology procedures have been carried out with ever reducing exposure to ionising radiation, and multiple techniques have been established to achieve ZERO exposure. Of course, these techniques should all be applied when contemplating an invasive mapping and ablation procedure during pregnancy. The role of the cardio-obstetrics team in planning and performing such procedures is paramount. Careful assessment of the pregnant mother and her unborn child is mandatory. Only with good preparation is a complete understanding of both cardiac anatomy and physiology achievable, which is a pre-requisite of a successful ablation outcome. Various aspects of the ablation procedure itself are discussed and evaluated from the perspective of all team members involved, including the obstetrician, the anaesthetist and the electrophysiologist. This review aims to inform the reader about the techniques available and reports on the published outcomes for ablations during pregnancy in the last decade.
Literatur
1.
Zurück zum Zitat Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M et al (2018) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 39(34):3165–3241CrossRef Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M et al (2018) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 39(34):3165–3241CrossRef
2.
Zurück zum Zitat Greutmann M, Pieper PG (2015) Pregnancy in women with congenital heart disease. Eur Heart J 36(37):2491–2499CrossRef Greutmann M, Pieper PG (2015) Pregnancy in women with congenital heart disease. Eur Heart J 36(37):2491–2499CrossRef
3.
Zurück zum Zitat Li MM, Sang CH, Jiang CX, Guo XY, Li SN, Wang W et al (2019) Maternal arrhythmia in structurally normal heart: prevalence and feasibility of catheter ablation without fluoroscopy. Pacing Clin Electrophysiol 42(12):1566–1572CrossRef Li MM, Sang CH, Jiang CX, Guo XY, Li SN, Wang W et al (2019) Maternal arrhythmia in structurally normal heart: prevalence and feasibility of catheter ablation without fluoroscopy. Pacing Clin Electrophysiol 42(12):1566–1572CrossRef
4.
Zurück zum Zitat Karaoguz MR, Yurtseven E, Aslan G, Deliormanli BG, Adiguzel O, Gonen M et al (2019) The quality of ECG data acquisition, and diagnostic performance of a novel adhesive patch for ambulatory cardiac rhythm monitoring in arrhythmia detection. J Electrocardiol 54:28–35CrossRef Karaoguz MR, Yurtseven E, Aslan G, Deliormanli BG, Adiguzel O, Gonen M et al (2019) The quality of ECG data acquisition, and diagnostic performance of a novel adhesive patch for ambulatory cardiac rhythm monitoring in arrhythmia detection. J Electrocardiol 54:28–35CrossRef
5.
Zurück zum Zitat Al-Alusi MA, Ding E, McManus DD, Lubitz SA (2019) Wearing your heart on your sleeve: the future of cardiac rhythm monitoring. Curr Cardiol Rep 21(12):158CrossRef Al-Alusi MA, Ding E, McManus DD, Lubitz SA (2019) Wearing your heart on your sleeve: the future of cardiac rhythm monitoring. Curr Cardiol Rep 21(12):158CrossRef
6.
Zurück zum Zitat Keegan J, Jhooti P, Babu-Narayan SV, Drivas P, Ernst S, Firmin DN (2014) Improved respiratory efficiency of 3D late gadolinium enhancement imaging using the continuously adaptive windowing strategy (CLAWS). Magn Reson Med 71(3):1064–1074CrossRef Keegan J, Jhooti P, Babu-Narayan SV, Drivas P, Ernst S, Firmin DN (2014) Improved respiratory efficiency of 3D late gadolinium enhancement imaging using the continuously adaptive windowing strategy (CLAWS). Magn Reson Med 71(3):1064–1074CrossRef
7.
Zurück zum Zitat Magun E, DeFilippis EM, Noble S, LaSala A, Waksmonski C, D’Alton ME et al (2020) Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol 76(18):2102–2113CrossRef Magun E, DeFilippis EM, Noble S, LaSala A, Waksmonski C, D’Alton ME et al (2020) Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol 76(18):2102–2113CrossRef
8.
Zurück zum Zitat Vladinov G, Fermin L, Longini R, Ramos Y, Maratea E Jr. (2018) Choosing the anesthetic and sedative drugs for supraventricular tachycardia ablations: a focused review. Pacing Clin Electrophysiol 41(11):1555–1563CrossRef Vladinov G, Fermin L, Longini R, Ramos Y, Maratea E Jr. (2018) Choosing the anesthetic and sedative drugs for supraventricular tachycardia ablations: a focused review. Pacing Clin Electrophysiol 41(11):1555–1563CrossRef
9.
Zurück zum Zitat Paech C, Wagner F, Strehlow V, Gebauer RA (2019) Drug-induced loss of preexcitation in pediatric patients with WPW pattern during electrophysiologic study. Pediatr Cardiol 40(1):194–197CrossRef Paech C, Wagner F, Strehlow V, Gebauer RA (2019) Drug-induced loss of preexcitation in pediatric patients with WPW pattern during electrophysiologic study. Pediatr Cardiol 40(1):194–197CrossRef
10.
Zurück zum Zitat Kim YH, Chen SA, Ernst S, Guzman CE, Han S, Kalarus Z et al (2020) 2019 APHRS expert consensus statement on three-dimensional mapping systems for tachycardia developed in collaboration with HRS, EHRA, and LAHRS. J Arrhythm 36(2):215–270CrossRef Kim YH, Chen SA, Ernst S, Guzman CE, Han S, Kalarus Z et al (2020) 2019 APHRS expert consensus statement on three-dimensional mapping systems for tachycardia developed in collaboration with HRS, EHRA, and LAHRS. J Arrhythm 36(2):215–270CrossRef
11.
Zurück zum Zitat Misra S, van Dam P, Chrispin J, Assis F, Keramati A, Kolandaivelu A et al (2018) Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts. J Electrocardiol 51(5):801–808CrossRef Misra S, van Dam P, Chrispin J, Assis F, Keramati A, Kolandaivelu A et al (2018) Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts. J Electrocardiol 51(5):801–808CrossRef
12.
Zurück zum Zitat Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C et al (2020) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 41(5):655–720CrossRef Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C et al (2020) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 41(5):655–720CrossRef
13.
Zurück zum Zitat Ueda A, Suman-Horduna I, Mantziari L, Gujic M, Marchese P, Ho SY et al (2013) Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: a single-center experience in 116 patients. Circ Arrhythm Electrophysiol 6(3):606–613CrossRef Ueda A, Suman-Horduna I, Mantziari L, Gujic M, Marchese P, Ho SY et al (2013) Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: a single-center experience in 116 patients. Circ Arrhythm Electrophysiol 6(3):606–613CrossRef
14.
Zurück zum Zitat Baykaner T, Quadros KK, Thosani A, Yasmeh B, Mitra R, Liu E et al (2020) Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches. Pacing Clin Electrophysiol 43(1):12–18CrossRef Baykaner T, Quadros KK, Thosani A, Yasmeh B, Mitra R, Liu E et al (2020) Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches. Pacing Clin Electrophysiol 43(1):12–18CrossRef
16.
Zurück zum Zitat Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J et al (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109(12):1472–1475CrossRef Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J et al (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109(12):1472–1475CrossRef
17.
Zurück zum Zitat Szumowski L, Walczak F, Dangel J, Szufladowicz E, Bodalski R, Derejko P et al (2006) Ablation of atypical, fast atrio-ventricular nodal tachycardia in a pregnant woman—a case report. Kardiol Pol 64(2):221–224PubMed Szumowski L, Walczak F, Dangel J, Szufladowicz E, Bodalski R, Derejko P et al (2006) Ablation of atypical, fast atrio-ventricular nodal tachycardia in a pregnant woman—a case report. Kardiol Pol 64(2):221–224PubMed
18.
Zurück zum Zitat Ferguson JD, Helms A, Mangrum JM, DiMarco JP (2011) Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman. J Cardiovasc Electrophysiol 22(3):346–349CrossRef Ferguson JD, Helms A, Mangrum JM, DiMarco JP (2011) Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman. J Cardiovasc Electrophysiol 22(3):346–349CrossRef
19.
Zurück zum Zitat Manjaly ZR, Sachdev B, Webb T, Rajappan K (2011) Ablation of arrhythmia in pregnancy can be done safely when necessary. Eur J Obstet Gynecol Reprod Biol 157(1):116–117CrossRef Manjaly ZR, Sachdev B, Webb T, Rajappan K (2011) Ablation of arrhythmia in pregnancy can be done safely when necessary. Eur J Obstet Gynecol Reprod Biol 157(1):116–117CrossRef
20.
Zurück zum Zitat Wu H, Ling LH, Lee G, Kistler PM (2012) Successful catheter ablation of incessant atrial tachycardia in pregnancy using three-dimensional electroanatomical mapping with minimal radiation. Intern Med J 42(6):709–712CrossRef Wu H, Ling LH, Lee G, Kistler PM (2012) Successful catheter ablation of incessant atrial tachycardia in pregnancy using three-dimensional electroanatomical mapping with minimal radiation. Intern Med J 42(6):709–712CrossRef
21.
Zurück zum Zitat Wang NC, Shen C, McLaughlin TJ, Li JZ, Hauspurg A, Berlacher KL et al (2020) Maternal focal atrial tachycardia during pregnancy: a systematic review. J Cardiovasc Electrophysiol 31(11):2982–2997CrossRef Wang NC, Shen C, McLaughlin TJ, Li JZ, Hauspurg A, Berlacher KL et al (2020) Maternal focal atrial tachycardia during pregnancy: a systematic review. J Cardiovasc Electrophysiol 31(11):2982–2997CrossRef
22.
Zurück zum Zitat Driver K, Chisholm CA, Darby AE, Malhotra R, Dimarco JP, Ferguson JD (2015) Catheter ablation of arrhythmia during pregnancy. J Cardiovasc Electrophysiol 26(6):698–702CrossRef Driver K, Chisholm CA, Darby AE, Malhotra R, Dimarco JP, Ferguson JD (2015) Catheter ablation of arrhythmia during pregnancy. J Cardiovasc Electrophysiol 26(6):698–702CrossRef
23.
Zurück zum Zitat Raman AS, Sharma S, Hariharan R (2015) Minimal use of fluoroscopy to reduce fetal radiation exposure during radiofrequency catheter ablation of maternal supraventricular tachycardia. Tex Heart Inst J 42(2):152–154CrossRef Raman AS, Sharma S, Hariharan R (2015) Minimal use of fluoroscopy to reduce fetal radiation exposure during radiofrequency catheter ablation of maternal supraventricular tachycardia. Tex Heart Inst J 42(2):152–154CrossRef
24.
Zurück zum Zitat Omaygenc MO, Karaca IO, Guler E, Kizilirmak F, Cakal B, Gunes HM et al (2015) Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure. Heart Rhythm 12(5):1057–1061CrossRef Omaygenc MO, Karaca IO, Guler E, Kizilirmak F, Cakal B, Gunes HM et al (2015) Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure. Heart Rhythm 12(5):1057–1061CrossRef
25.
Zurück zum Zitat Bigelow AM, Crane SS, Khoury FR, Clark JM (2015) Catheter ablation of supraventricular tachycardia without fluoroscopy during pregnancy. Obstet Gynecol 125(6):1338–1341CrossRef Bigelow AM, Crane SS, Khoury FR, Clark JM (2015) Catheter ablation of supraventricular tachycardia without fluoroscopy during pregnancy. Obstet Gynecol 125(6):1338–1341CrossRef
26.
Zurück zum Zitat Chen G, Sun G, Xu R, Chen X, Yang L, Bai Y et al (2016) Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: two case reports and literature review. Medicine 95(32):e4487CrossRef Chen G, Sun G, Xu R, Chen X, Yang L, Bai Y et al (2016) Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: two case reports and literature review. Medicine 95(32):e4487CrossRef
27.
Zurück zum Zitat Prolic Kalinsek T, Jan M, Rupar K, Razen L, Antolic B, Zizek D (2017) Zero-fluoroscopy catheter ablation of concealed left accessory pathway in a pregnant woman. Europace 19(8):1384CrossRef Prolic Kalinsek T, Jan M, Rupar K, Razen L, Antolic B, Zizek D (2017) Zero-fluoroscopy catheter ablation of concealed left accessory pathway in a pregnant woman. Europace 19(8):1384CrossRef
28.
Zurück zum Zitat Rossi L, Penela D, Villani GQ (2017) Intracardiac echocardiography catheter-guided zero fluoroscopy transeptal puncture technique for ablation of left-sided accessory pathway in a pregnant woman. Europace 19(11):1825CrossRef Rossi L, Penela D, Villani GQ (2017) Intracardiac echocardiography catheter-guided zero fluoroscopy transeptal puncture technique for ablation of left-sided accessory pathway in a pregnant woman. Europace 19(11):1825CrossRef
29.
Zurück zum Zitat Kozluk E, Piatkowska A, Kiliszek M, Lodzinski P, Malkowska S, Balsam P et al (2017) Catheter ablation of cardiac arrhythmias in pregnancy without fluoroscopy: a case control retrospective study. Adv Clin Exp Med 26(1):129–134CrossRef Kozluk E, Piatkowska A, Kiliszek M, Lodzinski P, Malkowska S, Balsam P et al (2017) Catheter ablation of cardiac arrhythmias in pregnancy without fluoroscopy: a case control retrospective study. Adv Clin Exp Med 26(1):129–134CrossRef
30.
Zurück zum Zitat Karbarz D, Stec PJ, Deutsch K, Sledz J, Stec S (2017) Zero-fluoroscopy catheter ablation of symptomatic pre-excitation from non-coronary cusp during pregnancy. Kardiol Pol 75(12):1351CrossRef Karbarz D, Stec PJ, Deutsch K, Sledz J, Stec S (2017) Zero-fluoroscopy catheter ablation of symptomatic pre-excitation from non-coronary cusp during pregnancy. Kardiol Pol 75(12):1351CrossRef
31.
Zurück zum Zitat Kaspar G, Sanam K, Gundlapalli S, Shah D (2018) Successful fluoroless radiofrequency catheter ablation of supraventricular tachycardia during pregnancy. Clin Case Rep 6(7):1334–1337CrossRef Kaspar G, Sanam K, Gundlapalli S, Shah D (2018) Successful fluoroless radiofrequency catheter ablation of supraventricular tachycardia during pregnancy. Clin Case Rep 6(7):1334–1337CrossRef
32.
Zurück zum Zitat Liu W, Qi S, Cai H, Wang D, Ru L (2019) Non-fluoroscopic radiofrequency ablation of left atrial appendage tachycardia during early pregnancy. Braz J Cardiovasc Surg 34(4):495–498CrossRef Liu W, Qi S, Cai H, Wang D, Ru L (2019) Non-fluoroscopic radiofrequency ablation of left atrial appendage tachycardia during early pregnancy. Braz J Cardiovasc Surg 34(4):495–498CrossRef
33.
Zurück zum Zitat Jeong HK, Yoon N, Park HW, Cho JG (2020) Radiofrequency catheter ablation without radiation exposure in a 13th week pregnant woman with Wolff-Parkinson-White syndrome. Rev Cardiovasc Med 21(2):303–307CrossRef Jeong HK, Yoon N, Park HW, Cho JG (2020) Radiofrequency catheter ablation without radiation exposure in a 13th week pregnant woman with Wolff-Parkinson-White syndrome. Rev Cardiovasc Med 21(2):303–307CrossRef
Metadaten
Titel
Catheter mapping and ablation during pregnancy
verfasst von
Adele Greyling
Caterina Vlachou
Stefan Ailoaei
Tina Buchholz
Bettina Toth
Professor Sabine Ernst, MD PhD
Publikationsdatum
29.03.2021
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 2/2021
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-021-00756-5

Weitere Artikel der Ausgabe 2/2021

Herzschrittmachertherapie + Elektrophysiologie 2/2021 Zur Ausgabe

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP)

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP)

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.